Pharmaceutical

When Pharmaceutical company discover new molecules that are going to become a drug, there is an obvious step where they manufacture the API – Active Pharmaceutical Ingredient, but beyond that, they also need to make sure that the drug is packaged right as a tablet or capsule, is bio-available and there is a big branch…

Tufts Center for the Study of Drug Development does research on drug development and publishes regular reports on drug development. The reports are primarily research conducting by the Center on the current trends in drug development, meetings, forums, courses and discussions. They do not come up with novel methods for drug development but rather act…

Take an example of failed target validation. Eli Lilly is just one company but this could be true of almost all the pharmaceutical companies. Eli Lilly announced in August 2012, that they have stopped “ongoing clinical studies investigating pomaglumetad methionil, also known as mGlu2/3, for the treatment of patients suffering from schizophrenia” in Phase 3….

Pharmaceutical companies are thought has rich giants with many resources available to them. However, they optimize manufacturing costs for small molecule chemical entities by outsourcing parts of the manufacturing, forming alliances with chemistry suppliers or basing their operations in low cost countries, like Puerto Rico. This works well for chemistry but for biological entity manufacturing,…